1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Cancer of Prostate in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Ho, CT; Hseu, YC; Kao, JY; Kuo, PT; Lin, VC; Lin, YC; Way, TD; Yang, HL | 1 |
Hu, H; Jiang, C; Kim, SH; Lee, EO; Lee, HJ; Lü, J; Wang, L; Xiang, Q; Zhang, J; Zhao, Y | 1 |
Hu, H; Kim, SH; Lee, HJ; Lü, J; Zhang, J | 1 |
Huang, CH; Kao, JY; Kuo, PT; Lin, JK; Lin, TP; Liu, LC; Way, TD | 1 |
Chai, Y; Hu, H; Kim, SH; Lee, HJ; Lü, J; Wang, L; Zhang, J | 1 |
Jeong, SJ; Kim, HC; Kim, HS; Kim, SH; Lee, HJ; Lim, S; Lü, J; Park, KY | 1 |
Higgins, LA; Kim, KH; Kim, SH; Li, L; Liao, JD; Lu, J; Nkhata, K; Shaik, AA; Wang, L; Xing, C; Zhang, J; Zhang, Y | 1 |
Gho, YS; Ji, ST; Lee, HM; Lee, SJ; Lee, SR; Mar, W | 1 |
8 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Cancer of Prostate
Article | Year |
---|---|
Penta-O-galloyl-β-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells.
Topics: Bone Neoplasms; Cell Line, Tumor; Epidermal Growth Factor; Eukaryotic Initiation Factor-3; Gene Expression; Humans; Hydrolyzable Tannins; Male; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; TOR Serine-Threonine Kinases; Transfection | 2014 |
Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-X Protein; Caspases; Cell Line, Tumor; Cell Proliferation; Cell-Free System; G1 Phase; Humans; Hydrogen Peroxide; Hydrolyzable Tannins; Interleukin-6; Intracellular Space; Male; Mice; Mice, Nude; Prostatic Neoplasms; S Phase; STAT3 Transcription Factor; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2008 |
Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1.
Topics: Amino Acid Chloromethyl Ketones; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Cyclin D1; DNA Replication; Humans; Hydrolyzable Tannins; Male; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms | 2009 |
Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Humans; Hydrolyzable Tannins; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Prostatic Neoplasms; RNA, Messenger; Transcription, Genetic | 2009 |
Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
Topics: Adenine; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Activation; Gene Knockdown Techniques; GTPase-Activating Proteins; Humans; Hydrolyzable Tannins; Male; Membrane Proteins; Mice; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sirolimus; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay | 2009 |
1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
Topics: 1-Phosphatidylinositol 4-Kinase; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Capillaries; Cell Line, Tumor; Endothelial Cells; Endothelium, Vascular; Humans; Hydrolyzable Tannins; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Phosphorylation; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Umbilical Veins; Vascular Endothelial Growth Factor A | 2010 |
Mouse prostate proteome changes induced by oral pentagalloylglucose treatment suggest targets for cancer chemoprevention.
Topics: Administration, Oral; Animals; Biomarkers; Blotting, Western; Body Weight; Hydrolyzable Tannins; Male; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Organ Size; Prostate; Prostatic Neoplasms; Proteome; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor.
Topics: Cell Division; Cell Movement; Collagen; Drug Combinations; Endothelium, Vascular; Fibrosarcoma; Humans; Hydrolyzable Tannins; Laminin; Male; Paeonia; Plant Extracts; Prostatic Neoplasms; Protein Binding; Proteoglycans; Receptors, Vascular Endothelial Growth Factor; Sodium-Potassium-Exchanging ATPase; Tannins; Umbilical Veins; Vascular Endothelial Growth Factor A | 2004 |